{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:17:45Z","timestamp":1793647065556,"version":"4.5.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.xphs.2023.12.020","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T21:01:02Z","timestamp":1705093262000},"page":"1094-1112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Introducing the Dynamic Well-Stirred Model for Predicting Hepatic Clearance and Extraction Ratio"],"prefix":"10.1016","volume":"113","author":[{"given":"Zhengyin","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Carione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicky","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane R.","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis E.C.A.","family":"Hop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.xphs.2023.12.020_bib0001","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1021\/acs.jmedchem.8b01263","article-title":"Clearance in drug design","volume":"62","author":"Smith","year":"2019","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.xphs.2023.12.020_bib0002","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1208\/s12248-022-00735-9","article-title":"Current approaches for predicting human PK for small molecule development candidates: findings from the IQ human PK prediction working group survey","volume":"24","author":"Petersson","year":"2022","journal-title":"AAPS J"},{"issue":"2","key":"10.1016\/j.xphs.2023.12.020_bib0003","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0022-3565(25)30786-X","article-title":"Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance","volume":"200","author":"Rane","year":"1977","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"10.1016\/j.xphs.2023.12.020_bib0004","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0006-2952(94)90520-7","article-title":"Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance","volume":"47","author":"Houston","year":"1994","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"10.1016\/j.xphs.2023.12.020_bib0005","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0090-9556(24)14938-0","article-title":"Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes","volume":"27","author":"Obach","year":"1999","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"10.1016\/j.xphs.2023.12.020_bib0006","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/dmd.30.8.892","article-title":"Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: an application of serum incubation method","volume":"30","author":"Shibata","year":"2002","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.xphs.2023.12.020_bib0007","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1124\/dmd.105.004259","article-title":"A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes","volume":"33","author":"Riley","year":"2005","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.xphs.2023.12.020_bib0008","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1124\/dmd.106.011569","article-title":"Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance","volume":"35","author":"Brown","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"10.1016\/j.xphs.2023.12.020_bib0009","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1007\/s11095-010-0218-3","article-title":"Prediction of human metabolic clearance from in vitro systems: retrospective analysis and prospective view","volume":"27","author":"Hallifax","year":"2010","journal-title":"Pharm Res"},{"issue":"8","key":"10.1016\/j.xphs.2023.12.020_bib0010","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/jps.23202","article-title":"Evaluation of hepatic clearance prediction using in vitro data: emphasis on fraction unbound in plasma and drug ionisation using a database of 107 drugs","volume":"101","author":"Hallifax","year":"2012","journal-title":"J Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2023.12.020_bib0011","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1124\/dmd.117.077040","article-title":"Clearance prediction methodology needs fundamental improvement: trends common to rat and human hepatocytes\/microsomes and implications for experimental methodology","volume":"45","author":"Wood","year":"2017","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.xphs.2023.12.020_bib0012","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/dmd.120.000294","article-title":"Impact of plasma protein binding in drug clearance prediction: a database analysis of published studies and implications for in vitro in vivo extrapolation","volume":"49","author":"Francis","year":"2021","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"10.1016\/j.xphs.2023.12.020_bib0013","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1021\/acs.jmedchem.0c01930","article-title":"Successful and unsuccessful prediction of human hepatic clearance for lead optimization","volume":"64","author":"Sodhi","year":"2021","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.xphs.2023.12.020_bib0014","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/jps.23502","article-title":"Toward a new paradigm for the efficient in vitro-in vivo extrapolation of metabolic clearance in humans from hepatocyte data","volume":"102","author":"Poulin","year":"2013","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2023.12.020_bib0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1124\/dmd.121.000677","article-title":"Does addition of protein to hepatocyte or microsomal in vitro incubations provide a useful improvement in in vitro-in vivo extrapolation predictability?","volume":"50","author":"Kameyama","year":"2022","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"10.1016\/j.xphs.2023.12.020_bib0016","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF01059688","article-title":"Hepatic clearance of drugs. I. Theoretical considerations of a \u201cwell-stirred\u201d model and a \u201cparallel tube\u201d model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance","volume":"5","author":"Pang","year":"1977","journal-title":"J Pharmacokinet Biop"},{"issue":"4","key":"10.1016\/j.xphs.2023.12.020_bib0017","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/cpt1975184377","article-title":"A physiological approach to hepatic drug clearance","volume":"18","author":"Wilkinson","year":"1975","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.xphs.2023.12.020_bib0018","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.xphs.2018.10.011","article-title":"Improving confidence in the determination of free fraction for highly bound drugs using bidirectional equilibrium dialysis","volume":"108","author":"Chen","year":"2019","journal-title":"J Pharm Sci"},{"issue":"20","key":"10.1016\/j.xphs.2023.12.020_bib0019","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1039\/c3an01116j","article-title":"Correlation of in vitro and in vivo plasma protein binding using ultracentrifugation and UPLC-tandem mass spectrometry","volume":"138","author":"Srikanth","year":"2013","journal-title":"Analyst"},{"issue":"9","key":"10.1016\/j.xphs.2023.12.020_bib0020","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/jps.23614","article-title":"Plasma protein binding: from discovery to development","volume":"102","author":"Bohnert","year":"2013","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2023.12.020_bib0021","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF01059340","article-title":"Influence of plasma protein binding kinetics on hepatic clearance assessed from a \"tube\" model and a \"well-stirred\" model","volume":"9","author":"Jansen","year":"1981","journal-title":"J Pharmacokinet Biopharm"},{"issue":"5","key":"10.1016\/j.xphs.2023.12.020_bib0022","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1073\/pnas.82.5.1563","article-title":"Dissociation from albumin: a potentially rate-limiting step in the clearance of substances by the liver","volume":"82","author":"Weisiger","year":"1985","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"10.1016\/j.xphs.2023.12.020_bib0023","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1021\/acs.analchem.2c04864","article-title":"New methodology for determining plasma protein binding kinetics using an enzyme reporter assay coupling with high resolution mass spectrometry","volume":"95","author":"Yan","year":"2023","journal-title":"Anal Chem"},{"issue":"3","key":"10.1016\/j.xphs.2023.12.020_bib0024","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1124\/dmd.106.013359","article-title":"Misuse of the well-stirred model of hepatic drug clearance","volume":"35","author":"Yang","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"10.1016\/j.xphs.2023.12.020_bib0025","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1124\/dmd.108.020479","article-title":"Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds","volume":"36","author":"Obach","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.xphs.2023.12.020_bib0026","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1067\/mcp.2000.108678","article-title":"Race and sex influence clearance of nifedipine: results of a population study","volume":"68","author":"Krecic-Shepard","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.xphs.2023.12.020_bib0027","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/j.1552-4604.1986.tb02946.x","article-title":"Pharmacokinetics of diphenhydramine and a demethylated metabolite following intravenous and oral administration","volume":"26","author":"Blyden","year":"1986","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.xphs.2023.12.020_bib0028","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s002280050182","article-title":"Absolute bioavailability of oral immediate and slow release fluphenazine in healthy volunteers","volume":"51","author":"Koytchev","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.xphs.2023.12.020_bib0029","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1124\/dmd.115.068601","article-title":"Mechanistic modeling to predict midazolam metabolite exposure from in vitro data","volume":"44","author":"Nguyen","year":"2016","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"10.1016\/j.xphs.2023.12.020_bib0030","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1080\/00498250802446286","article-title":"Reliability of human cryopreserved hepatocytes and liver microsomes as in vitro systems to predict metabolic clearance","volume":"38","author":"Stringer","year":"2008","journal-title":"Xenobiotica"},{"issue":"9","key":"10.1016\/j.xphs.2023.12.020_bib0031","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1124\/dmd.112.046425","article-title":"A novel relay method for determining low-clearance values","volume":"40","author":"Di","year":"2012","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"10.1016\/j.xphs.2023.12.020_bib0032","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1124\/dmd.113.053397","article-title":"Meeting the challenge of predicting hepatic clearance of compounds slowly metabolized by cytochrome p450 using a novel hepatocyte model","volume":"41","author":"Chan","year":"2013","journal-title":"Hepatopac Drug Metab Dispos"},{"issue":"7","key":"10.1016\/j.xphs.2023.12.020_bib0033","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/j.xphs.2019.02.009","article-title":"In vitro-in vivo extrapolation and hepatic clearance dependent underprediction","volume":"108","author":"Bowman","year":"2019","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.12.020_bib0034","series-title":"Clinical Pharmacokinetics: Concepts and Applications","author":"Rowland","year":"1995"},{"issue":"20","key":"10.1016\/j.xphs.2023.12.020_bib0035","doi-asserted-by":"crossref","first-page":"8238","DOI":"10.1021\/jm5007935","article-title":"Rational use of plasma protein and tissue binding data in drug design","volume":"57","author":"Liu","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.xphs.2023.12.020_bib0036","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejps.2018.08.008","article-title":"An examination of protein binding and protein-facilitated uptake relating to in vitro-in vivo extrapolation","volume":"123","author":"Bowman","year":"2018","journal-title":"Eur J Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2023.12.020_bib0037","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1124\/dmd.116.071514","article-title":"Hepatic clearance predictions from in vitro-in vivo extrapolation and the biopharmaceutics drug disposition classification system","volume":"44","author":"Bowman","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2023.12.020_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106268","article-title":"Evidence of the need for modified well-stirred model in vitro to in vivo extrapolation","volume":"177","author":"Chang","year":"2022","journal-title":"Eur J Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2023.12.020_bib0039","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1124\/dmd.120.000131","article-title":"Evaluation of the disconnect between hepatocyte and microsome intrinsic clearance and in vitro in vivo extrapolation performance","volume":"48","author":"Williamson","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2023.12.020_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111855","article-title":"Precisely adjusting the hepatic clearance of highly extracted drugs using the modified well-stirred model","volume":"141","author":"Hsu","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.xphs.2023.12.020_bib0041","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1208\/s12248-021-00591-z","article-title":"There is only one valid definition of clearance: critical examination of clearance concepts reveals the potential for errors in clinical drug dosing decisions","volume":"23","author":"Benet","year":"2021","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2023.12.020_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106134","article-title":"A myth of the well-stirred model: is the well-stirred model good for high clearance drugs?","volume":"172","author":"Dong","year":"2022","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.12.020_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.07.025","article-title":"Hepatic clearance concepts and misconceptions: why the well-stirred model is still used even though it is not physiologic reality?","volume":"169","author":"Pang","year":"2019","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.xphs.2023.12.020_bib0044","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1124\/dmd.121.000637","article-title":"In defense of current concepts and applications of clearance in drug development and therapeutics","volume":"50","author":"Rowland","year":"2022","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2023.12.020_bib0045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejps.2018.08.011","article-title":"Discussions on the hepatic well-stirred model: re-derivation from the dispersion model and re-analysis of the lidocaine data","volume":"124","author":"Dong","year":"2018","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2023.12.020_bib0046","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/cpt.2482","article-title":"Can in vitro-in vivo extrapolation be successful? recognizing the incorrect clearance assumptions","volume":"111","author":"Benet","year":"2022","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.xphs.2023.12.020_bib0047","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1124\/dmd.120.090530","article-title":"Are there any experimental perfusion data that preferentially support the dispersion and parallel-tube models over the well-stirred model of organ elimination?","volume":"48","author":"Sodhi","year":"2020","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"10.1016\/j.xphs.2023.12.020_bib0048","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1124\/dmd.121.000784","article-title":"Application of empirical scalars to enable early prediction of human hepatic clearance using IVIVE in drug discovery: an evaluation of 173 drugs","volume":"50","author":"Jones","year":"2022","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"10.1016\/j.xphs.2023.12.020_bib0049","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1002\/jps.23288","article-title":"Comparative assessment of in vitro-in vivo extrapolation method used for predicting hepatic metabolic clearance of drugs","volume":"101","author":"Poulin","year":"2012","journal-title":"J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923005683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923005683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:44:03Z","timestamp":1758361443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354923005683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0022354923005683"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.12.020","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Introducing the Dynamic Well-Stirred Model for Predicting Hepatic Clearance and Extraction Ratio","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}